R&D Process Development Symposium
Seminar Training

R&D Process Development Seminar – Cambridge, MA

Seminar Training

2018 Symposium focusing on R&D Process Development

R&D Process Development Seminar – Cambridge, MA
R&D Process Development Seminar – Cambridge, MA

At the June 27 R&D Process Development Seminar, you will interact and network with peers at the leading edge of chemistry, chemical engineering, and bioprocessing.  Learn about improving efficiency and innovation in synthetic reaction development, process chemistry, crystallization, safety, and scale-up. 

The program features presentations and case studies from industrial and academic experts, who will discuss:

  • How researchers are addressing current challenges in the pharmaceutical, fine chemical, bioprocessing, and academic fields
  • Specific methods to modernize synthesis, sustain a culture of safety, and provide insight to every reaction or crystallization
  • Methods to help your company transform productivity and scale up from lab to plant

This seminar is free of charge but registration is required.  Register today as space is limited.  The event will take place between 9am and 5pm on June 27.  Speakers include:

  • Nucleation and Growth Kinetics for Combined Cooling and Anti-Solvent Crystallization in an MSMPR System - Estimating Solvent Dependency
    Jennifer Schall, PhD Candidate - Myerson Research Group, MIT, Cambridge, MA
     
  • Model Predictive Temperature Control in Crystallization
    Dan Patience, Principal Engineer - Biogen Idec, Cambridge, MA
     
  • Particle Engineering to Ensure Successful Scale-up
    Miriam Kennedy, Technical Program Manager - APC Ltd, Dublin, Ireland
     
  • An Improved Process for Synthesis of the Epoxyketone Warhead of Carfilzomib
    Matthew Beaver and Peter Dornan, R&D Process Development Scientists - Amgen, Cambridge, MA
     
  • Integrating Process Analytical Technology (PAT) into a Flexible Lab Environment
    Michael Millonig, Senior Research Associate - Takeda Pharmaceuticals, Cambridge, MA

  • Process Safety Assessment and Route Selection Strategy for the Synthesis of Substituted Oxadiazoles
    Theodore Martinot, Process Research & Development Principal Scientist - Merck & Co, Inc., Boston, MA

  • Accelerating CTSR Proof of Concept
    Jerry Salan, CEO - Nalas Engineering Services

Register now to learn from experts and network with industry peers.

Event begins with registration at 8am.  Talks are from 9am to 5pm.

Cost
There is no fee to attend but registration is required.

 
 
 
 
 
 
 
Thank you for visiting www.mt.com. We have tried to optimize your experience while on the site, but we noticed that you are using an older version of a web browser. We would like to let you know that some features on the site may not be available or may not work as nicely as they would on a newer browser version. If you would like to take full advantage of the site, please update your web browser to help improve your experience while browsing www.mt.com.